LivaNova (LIVN) Competitors

$64.15
+1.23 (+1.95%)
(As of 05/3/2024 ET)

LIVN vs. ITGR, TMDX, CNMD, HAE, SLNO, INMD, BLFS, AXGN, OM, and MASI

Should you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Integer (ITGR), TransMedics Group (TMDX), CONMED (CNMD), Haemonetics (HAE), Soleno Therapeutics (SLNO), InMode (INMD), BioLife Solutions (BLFS), AxoGen (AXGN), Outset Medical (OM), and Masimo (MASI). These companies are all part of the "medical" sector.

LivaNova vs.

Integer (NYSE:ITGR) and LivaNova (NASDAQ:LIVN) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, media sentiment, profitability, community ranking, valuation, earnings and institutional ownership.

Integer has a beta of 1.12, indicating that its stock price is 12% more volatile than the S&P 500. Comparatively, LivaNova has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500.

Integer has a net margin of 6.01% compared to Integer's net margin of -2.68%. Integer's return on equity of 13.59% beat LivaNova's return on equity.

Company Net Margins Return on Equity Return on Assets
Integer6.01% 11.25% 5.69%
LivaNova -2.68%13.59%7.06%

In the previous week, LivaNova had 16 more articles in the media than Integer. MarketBeat recorded 27 mentions for LivaNova and 11 mentions for Integer. LivaNova's average media sentiment score of 0.80 beat Integer's score of 0.58 indicating that Integer is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integer
7 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LivaNova
5 Very Positive mention(s)
3 Positive mention(s)
13 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

LivaNova received 5 more outperform votes than Integer when rated by MarketBeat users. Likewise, 68.78% of users gave LivaNova an outperform vote while only 63.39% of users gave Integer an outperform vote.

CompanyUnderperformOutperform
IntegerOutperform Votes
374
63.39%
Underperform Votes
216
36.61%
LivaNovaOutperform Votes
379
68.78%
Underperform Votes
172
31.22%

99.3% of Integer shares are held by institutional investors. Comparatively, 97.6% of LivaNova shares are held by institutional investors. 2.0% of Integer shares are held by company insiders. Comparatively, 0.2% of LivaNova shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Integer currently has a consensus target price of $120.50, indicating a potential upside of 8.30%. LivaNova has a consensus target price of $66.20, indicating a potential upside of 3.20%. Given LivaNova's stronger consensus rating and higher probable upside, equities analysts plainly believe Integer is more favorable than LivaNova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67
LivaNova
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40

Integer has higher revenue and earnings than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integer$1.60B2.33$90.65M$2.8938.50
LivaNova$1.15B3.01$17.55M-$0.60-106.92

Summary

Integer beats LivaNova on 12 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LIVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LIVN vs. The Competition

MetricLivaNovaElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$3.47B$3.25B$5.01B$7.72B
Dividend YieldN/A1.67%2.89%3.95%
P/E Ratio-106.927.48165.6615.05
Price / Sales3.0167.342,456.5688.37
Price / Cash14.9066.1649.7336.12
Price / Book2.844.074.884.36
Net Income$17.55M$87.99M$103.85M$214.85M
7 Day Performance15.52%11.56%3.93%2.26%
1 Month Performance18.93%-3.02%-3.04%-2.35%
1 Year Performance35.11%4.17%4.24%9.00%

LivaNova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ITGR
Integer
1.9505 of 5 stars
$109.92
+0.1%
$120.50
+9.6%
+37.9%$3.68B$1.60B38.0310,500Insider Selling
Short Interest ↑
TMDX
TransMedics Group
1.9816 of 5 stars
$124.44
+5.8%
$119.00
-4.4%
+74.4%$4.07B$241.62M-366.00584Earnings Report
Analyst Report
Insider Selling
Analyst Revision
News Coverage
CNMD
CONMED
4.982 of 5 stars
$70.20
+2.7%
$107.86
+53.6%
-41.6%$2.16B$1.24B26.904,000Insider Buying
Positive News
HAE
Haemonetics
4.0338 of 5 stars
$93.39
+1.4%
$104.67
+12.1%
+16.8%$4.68B$1.27B37.963,034Upcoming Earnings
Short Interest ↑
Analyst Revision
News Coverage
SLNO
Soleno Therapeutics
3.4236 of 5 stars
$49.23
+3.6%
$55.60
+12.9%
+1,059.9%$1.64BN/A-16.5833Insider Selling
News Coverage
Gap Down
INMD
InMode
3.622 of 5 stars
$17.36
+0.7%
$32.80
+88.9%
-45.3%$1.46B$492.05M7.55581Analyst Report
Gap Up
BLFS
BioLife Solutions
2.3651 of 5 stars
$18.16
+3.9%
$23.40
+28.9%
+0.7%$822.65M$143.27M-11.95409Upcoming Earnings
AXGN
AxoGen
2.4045 of 5 stars
$5.88
-10.4%
$10.67
+81.4%
-35.7%$257.02M$159.01M-11.31426News Coverage
OM
Outset Medical
1.2393 of 5 stars
$3.00
+5.3%
$5.42
+80.6%
-85.0%$155.10M$130.38M-0.86480Upcoming Earnings
Gap Up
MASI
Masimo
3.5088 of 5 stars
$136.25
+1.7%
$137.43
+0.9%
-25.8%$7.09B$2.05B90.235,200Upcoming Earnings
Insider Selling

Related Companies and Tools

This page (NASDAQ:LIVN) was last updated on 5/5/2024 by MarketBeat.com Staff

From Our Partners